LegalFix
Sign In

§ 15-850. Prior authorizations for opioid antagonist.

MD Ins Code § 15-850 (2019) (N/A)
Copy with citation
Copy as parenthetical citation

(a)    In this section, “opioid antagonist” means:

(1)    naloxone hydrochloride; or

(2)    any other similarly acting and equally safe drug approved by the federal Food and Drug Administration for the treatment of a drug overdose.

(b)    (1)    This section applies to:

(i)    insurers and nonprofit health service plans that provide coverage for prescription drugs under individual, group, or blanket health insurance policies or contracts that are issued or delivered in the State; and

(ii)    health maintenance organizations that provide coverage for prescription drugs under individual or group contracts that are issued or delivered in the State.

(2)    An insurer, a nonprofit health service plan, or a health maintenance organization that provides coverage for prescription drugs through a pharmacy benefits manager is subject to the requirements of this section.

(c)    An entity subject to this section that includes on its formulary an opioid antagonist may apply a prior authorization requirement for an opioid antagonist only if the entity provides coverage for at least one formulation of the opioid antagonist without a prior authorization requirement.

Previous Section
§ 15-849. Coverage for abuse-deterrent opioid analgesic drug products
Next Section
§ 15-851. Prior authorization for drug products to treat opioid use disorder -- Prohibition.